Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new information regarding Crohn disease and its treatment with upadacitinib, replacing previous references to atopic dermatitis and its treatment. Additionally, the update includes new dates and a shift in the form of medication from an oral tablet to an oral solution.
    Difference
    7%
    Check dated 2025-03-11T04:40:30.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-24T21:07:38.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    3%
    Check dated 2025-02-10T09:54:04.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.2%
    Check dated 2025-02-03T08:35:45.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.2%
    Check dated 2025-01-19T22:50:20.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.6%
    Check dated 2025-01-12T18:13:35.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.